Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical hemostats and high awareness among physicians about the clinical benefits of biosurgical agents in various procedures.
This Medtech 360 Report provides high-level market metrics for biosurgical agents in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2033